ArticleTherapeutic advances in neurological disorders2020

Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE.

Ralf Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.